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 ABSTRACT 
 
 Toxoplasma gondii is a single-celled eukaryotic parasite that belongs to the 
Apicomplexan phylum.  Toxoplasma is an obligate intracellular parasite that is related to other 
important pathogens, such as, Plasmodium, the causative agent of malaria.  Toxoplasma can 
reproduce both sexually and asexually and asexual reproduction is central to the pathogenesis of 
this organism.  Asexual reproduction consists of two developmental stages, the tachyzoites, 
which grow rapidly and cause the acute infection and the bradyzoites, which grow slowly and 
cause the chronic infection.  
  
 We are interested in identifying the genes involved in the bradyzoite differentiation 
process in order to better understand the biology of the conversion between tachyzoites and 
bradyzoites.  To date, there are no drugs against the bradyzoite form, therefore, understanding 
which genes are involved in the conversion could lead to improved drug therapies.  In the 
laboratory, we are able to induce the transition from tachyzoites to bradyzoites by starving the 
parasites of carbon dioxide (CO2).  This method of induction renders them unable to synthesize 
pyrimidines, which stresses the parasites and causes them to switch to the dormant bradyzoite 
form.   Previous work in the Matrajt laboratory, using a forward genetic screen involving 
insertional mutagenesis, generated several parasite mutants that are unable to switch from 
tachyzoites to bradyzoites under CO2 starvation conditions.   
  
 In the current study, we performed whole genome-wide microarray analysis on 7 
bradyzoite differentiation mutants and our data suggest that the mutant parasites are ‘stuck’ in an 
intracellular state even when they are extracellular.  This result suggests a commonality of 
regulation for switching from state to state.  We have also characterized functionally related gene 
sets that are highly represented in the intracellular state and are able to identify genes that express 
most differently across all mutant strains, as well as, between mutant strains and wild type.  
Specifically, DNA replication genes are predominantly expressed during the intracellular state 
compared to the extracellular tachyzoite or bradyzoite states.  Interestingly, mutant extracellular 
tachyzoites also express these DNA replication genes.  Lastly, our data suggest a clear difference 
between the gene expression profiles of wild type extracellular and intracellular parasites.   
  
 In addition to the microarray studies, we have characterized the disrupted locus in one of 
the bradyzoite differentiation mutants, mutant B7.  A putative non-coding RNA (ncRNA), 
designated B41, has been physically disrupted in mutant B7 and its expression is developmentally 
regulated in wild type but reduced in the mutant.  B41 is a large, polyadenylated RNA that is 
alternatively spliced (1kb and 2.2kb) and has no open reading frame.  Two genes adjacent to the 
insertion site, B41 and EST 13803210 have mis-regulated expression in mutant B7.  
Overexpression studies of EST13803210 suggest that this EST does not play a key role in 
bradyzoite differentiation.  We also used luciferase reporter assays to test if the putative ncRNA, 
B41, regulates the expression of EST 13803210 and it does not.  Although we have been unable 
to elucidate the function of B41, our results suggest that this gene is responsible for the mutant 
phenotype since we were able to complement the mutant using a cosmid complementation system 
that restored the mutant phenotype. 
 
ii 
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CHAPTER 1:  INTRODUCTION 
1.1 General Biology of Toxoplasma gondii 
 Toxoplasma gondii is an obligate intracellular parasite that belongs to the phylum 
Apicomplexa, which includes other important pathogens, such as Plasmodium (causes 
malaria), Eimeria (causes poultry disease), and Cryptosporidium (causes gastrointestinal 
disease).  Most of the Toxoplasma isolates found in North America and Europe are 
classified into three lineages; type I, type II and type III [1], and those not belonging to 
these lineages are considered exotic strains.  In the past, identification of parasite strain 
type was performed by polymerase chain reaction- restriction fragment length 
polymorphism (PCR-RFLP)[2] and microsatellite typing [3].  Recently, Dubey et al., 
2006, developed a novel and ingenious method for strain type determination based on 
using 9 independent, non-linked genomic markers that enable the differentiation between 
types I, II, and III in a single restriction enzyme digestion for each marker [1].  Although 
each lineage is nearly identical at the DNA sequence level, there is great contrast in 
virulence in mice [1].  Type I strains are highly virulent in mice with an LD100 = 1, while 
type II and III strains are much less virulent with an LD100 > 103 [4]. 
 Toxoplasma is a single-celled eukaryotic organism that has the typical organelles 
found in other eukaryotes.  In addition, it contains a unique set of apical organelles.  The 
apical organelles include secretory machinery: rhoptries, micronemes and dense granules, 
and a plastid called the apicoplast.   
 The rhoptry is a club-shaped organelle that contains two types of proteins, rhoptry 
proteins (ROPs) and rhoptry neck proteins (RONs), plus lipid.  The lipid content is made 
 2
up of cholesterol and phospholipids and is responsible for the 'membrane swirls' seen in 
electron micrographs [5].  ROPs localize to the bulbous region of the rhoptries and the 
RONs localize to the neck region of this organelle [5].  Interestingly, these two types of 
proteins are separated in space within the rhoptry although there is no evidence of a 
physical barrier between the two regions [5].  It is well established that rhoptry proteins 
are secreted during invasion.  It is known that RONs 2, 4, and 5 form a complex with the 
microneme protein, AMA1, to structure/shape the moving junction [6, 7].  The moving 
junction forms a ring-shaped complex between the anterior boundary of the parasite and 
the host cell plasma membrane and is used by the parasite to pull itself into its host cell 
[5].  ROPs are known to localize to three different sites after secretion: (1) the lumen of 
the parasitophorous vacuole, (2) the parasitophorous vacuole membrane, or (3) the 
interior of the host cell [5].   
 Micronemes are small, cigar-shaped secretory organelles that are also involved in 
the process of invasion.  The number of microneme organelles per parasite depends on 
the species and the developmental stage [8].  When a parasite is hunting for a host cell to 
invade, it touches its host cell and calcium is released from stores within the parasite.  
This release in calcium triggers secretion of microneme proteins into the junction 
between the parasite and the host and this event allows adherence of the parasite to the 
host cell [9-11].  It is interesting to note that the products of the secretory organelles work 
together to accomplish biological processes such as invasion.  As described above, a 
microneme protein (AMA1) interacts with rhoptry proeins (RONs) to facilitate adhering 
and invading the host cell. 
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 The dense granules are spherical organelles that contain a high concentration of 
proteins as suggested by the overall density observed under a transmission electron 
microscope [8].  In contrast to the rhoptries and micronemes, the dense granules are 
localized throughout the parasite, secrete laterally (in contrast to apical secretion), and are 
involved in modifying the structure of the parasitophorous vacuole for the developing 
parasite [8].   It is not fully understood whether secretion from dense granules is 
constitutive or regulated, as there is evidence for both mechanisms.  It is possible that 
secretion is triggered in both fashions; constitutive release enhanced by the ADP-
ribosylation factor-1 (ARF-1) [12] and regulated release that occurs shortly after invasion 
and results in a massive discharge of protein into the parasitophorous vacuole [13].   
 The apicoplast is a chloroplast-like plastid that is unique to the Apicomplexa 
phylum and originated from a secondary endosymbiotic event (Figure 1).   
 Figure 1.  "A scheme for the origin and evolution of all plastids by primary and 
secondary endosymbiosis.” TRENDS in Genetics Vol.18No.11 Nov. 2002 [14].  







Back in evolutionary time, a heterotrophic eukaryote engulfed a photosynthetic algal cell 
[15].  Instead of digesting the algal cell, the eukaryote adopted it as a symbiont.  The 
secondary endosymbiotic event occurred when a common ancestor to Toxoplasma and 
other Apicomplexans engulfed the (previously mentioned) heterotrophic eukaryote [15].  
 The apicoplast is surrounded by four concentric membranes, which are the 
products of the primary and secondary endosymbiotic events.  The two inner membranes 
are the remnants of the inner and outer membranes of the algal chloroplast.  The third 
membrane that surrounds the two inner membranes represents the algal plasma 
membrane.  The outer membrane of the apicoplast is the vacuole membrane that was 
formed during the engulfment which resulted in the secondary endosymbiosis [15].  The 
apicoplast contains a 35kb circular DNA genome that has many chloroplast-like features 
including open reading frames with homology to RNA polymerases found in eubacteria, 
ribosomal proteins and rRNAs [16].  Interestingly, some of the molecules that localize to 
the apicoplast have proved to be successful drug targets in other systems, thus the 
apicoplast, not a part of mammalian cells, is a promising target for parasiticidal drugs 
against Toxoplasma gondii [15]. 
1.2 The life cycle of Toxoplasma gondii. 
 Toxoplasma gondii reproduces both sexually and asexually (Figure 2).   
  
Figure 2.  The life cycle of Toxoplasma gondii. 
The details of the Toxoplamsa gondii life cycle are discussed in the text. 
 
Sexual reproduction only occurs in the cat and begins when a cat ingests infectious 
oocysts or an animal that is infected with bradyzoite tissue cysts (Bogtish and Cheng 
1998).  The tissue cysts are resilient and are able to pass through the gastric fluids of the 
stomach unharmed.  They travel to the intestine where the bradyzoites are released from 
their resident cysts and infect intestinal cells, entering into the enteric phase of the sexual 
cycle.  The bradyzoites switch to tachyzoites and go through several rounds of 
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replication, then switch back to bradyzoites where they form macrogametes and 
microgametes, which fuse to form an oocyst.  Oocysts are released in cat feces and the 
sporozoites within the oocyst become infectious within a couple of days of maturation.  
The infectious sporozoites can then infect a variety of intermediate hosts, including; deer, 
sheep, cattle, humans, etc. (Bogtish and Cheng 1998).  Toxoplasma gondii has the ability 
to infect all nucleated mammalian cells studied to date and this is where asexual 
reproduction occurs.  Humans may eat raw or undercooked meat that contains bradyzoite 
cysts or may become infected from infectious sporozoites that have been released into an 
infected cat’s litter box.  Once an individual is infected with Toxoplasma gondii the 
parasites differentiate into fast-growing tachyzoites and disseminate throughout the body 
via macrophages.  In an immunocompetent individual, tachyzoites are eliminated by host 
immune responses within 7-10 days but tissue cysts containing the slow growing 
bradyzoites persist (because they are immunoprivileged) and are responsible for the 
chronic infection [17].  Several stress methods for inducing bradyzoite formation in vitro 
have been developed, including CO2 starvation, high pH, electron transport inhibitors and 
temperature stress [17].   
 When the asexual cycle of Toxoplasma gondii is thought of in the context of 
cellular states, we acknowledge a two state switching mechanism consisting of the 
tachyzoite and bradyzoite end states.   Extracellular tachyzoites invade host cells and 
replicate until they lyse the host cell.  But, if the intracellular state parasites sense a 
stressful environment, presumably via a host signal, then they will transition to the 
bradyzoite end state.  Likewise, if the bradyzoite state parasites sense a release of the 
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stress signal, they will transition back to the tachyzoite state, which after rapid replication 
and egress, will transition to an extracellular tachyzoite state.  The chronic infection 
poses a serious threat to immunocompromised individuals because once the immune 
system becomes repressed the bradyzoites can reactivate into tachyzoites and cause 
severe disease.  Given this information, it is clear that the asexual cycle is central to the 
pathogenesis of Toxoplasma gondii.    
1.3 Epidemiology and Risk Factors 
 Toxoplasma infection is one of the most common opportunistic diseases in the 
world today (http://www.cdc.gov/toxoplasmosis/epi.html).  In the United States, ~22% of 
the population is infected while the prevalence reaches > 95% in other areas of the world 
(http://www.cdc.gov/toxoplasmosis/epi.html).  Infection rates are highest in low altitude 
areas where the climate is very hot and humid 
(http://www.cdc.gov/toxoplasmosis/epi.html).  Infection with Toxoplasma can occur 
from eating raw or undercooked meat containing tissue cysts or through accidental 
ingestion of infectious sporozoites that have been released from cat feces.  In rare 
instances, infection occurs through blood transfusions and organ transplants 
(http://www.cdc.gov/toxoplasmosis/epi.html).  Toxoplasmosis causes severe disease in 
immunocompromised patients (AIDS patients, patients on chemotherapy, etc.) and can 
cause neurological disorders to the fetus if the mother becomes infected during pregnancy 
[17]. 
 Treatment of toxoplasmosis in immunocompetent individuals does not usually 
occur since the infection is generally asymptomatic in these patients.  However, women 
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who are pregnant and have never been infected with Toxoplasma might be treated with 
the drug Spiramycin to prevent infection of the placenta [18].  Spiramycin is not available 
throughout the world.  In fact, it is currently unavailable in the United States because it 
has not yet been approved by the USFDA [18].  Pyrimethamine and Sulfadiazine are 
commonly used to treat Toxoplasma infection unless the patient is allergic to sulfa drugs, 
in which case, that patient would be treated with Clindamycin [18].  Recently, a “golden 
bullet” drug strategy has been developed, where antibodies against tachyzoites are 
attached to gold nanorods and injected into the host [19].  The gold nanorods bind to 
Toxoplasma and then a laser is used to heat up and kill those parasites that are bound to 
the nanoparticles.  This method has not been tested in human patients yet, but proves to 
be another promising drug against toxoplasmosis.   
 Although the currently available drug therapies are useful in some situations, they 
are not ideal.  The major threat of Toxoplasma gondii infection is reactivation of the 
dormant bradyzoites during a chronic infection.  An ideal drug would either kill the 
bradyzoite form (during a chronic infection) or block formation of the bradyzoite form 
(preventative medicine) of the parasite so that this threat is eliminated.  Additionally, 
therapy that blocks the bradyzoite to tachyzoite transition would also protect the patient 
against reactivation during chronic disease. 
1.4 Bradyzoite Differentiation 
 During the conversion of tachyzoites to bradyzoites: replication rate decreases, 
differential gene expression occurs and there is a major reorganization of organelles.  
Tachyzoites and bradyzoites replicate by endodyogeny and endopolygeny [20].  
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Endodyogeny replication is synchronous and consists of the mother parasite producing 
two identical daughter parasites that engulf the mother.  Endopolygeny, also called 
schizogeny, occurs asynchronously and involves the mother parasite developing into 
several identical daughter parasites before cytokenesis.   In general, tachyzoites 
reproduce by endodyogeny with a doubling time of ~7 hours [21, 22], but do reproduce 
by endopolygeny ~0.5-5% of the time [23].  Bradyzoites mostly replicate by 
endodyogeny with a doubling time of  >12 hours but endopolygeny is observed in 16% 
(24h post induction) - 50% (48h post induction) of parasites as evidenced by positive 
Dolichos lectin (marker of expression of the cyst wall protein, CST1) staining of the cyst 
wall of these slow, replicating bradyzoites [20].  It is also well established that the timing 
of differentiation varies from vacuole to vacuole [20].  
 Several groups have studied gene expression patterns during the tachyzoite to 
bradyzoite transition process, observing both wild type and bradyzoite differentiation 
mutant parasite lines.  It is important to note that each study has used different parasite 
strains (predominantly, type I or II), different bradyzoite induction conditions 
(predominantly, CO2 starvation or alkaline (pH 8.1) conditions), and analyzed varying 
time points before and after induction [24, 25].  This information is a crucial 
consideration to have when comparing results across different studies.  In spite of these 
important differences, the overall biology of the transition is similar in each study.  
Before whole genome microarray chips were available, researchers generated Expressed 
Sequence Tag (EST) libraries and compared EST abundance between stages [25], and 
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generated cDNA microarrays [24] to study the gene expression profiles during 
conversion.   
 Serial analysis of gene expression (SAGE) is another molecular tool for 
quantifying gene expression levels for both known and unknown transcripts.  In brief, 
total RNA is incubated with oligo dT-bound magnetic beads and polyadenylated 
messengerRNA (mRNA) is captured by the dT oligomers.  The RNA is copied into 
complementary DNA (cDNA) which results in beads that contain the original oligo dT 
primer bound to cDNA that is a copy of the original mRNA.  Next, the 5’ end of the 
cDNA is cleaved leaving a ‘sticky’ end for a ‘docking’ molecule to attach.  A specialized 
enzyme binds to the docking molecule and cuts off a short segment of the cDNA 
molecule.  This results in a collection of short tags that represent each mRNA molecule 
represented in the original total RNA sample.   Each tag has the ability to bind to the end 
of other tags leading to the formation of a DNA tag concatemer, which is then amplified 
into millions of copies for analysis.   Finally, computer analysis counts each tag, assigns 
each tag to its cognate mRNA molecule, and tells the researcher which tags came from 
known genes and which tags represent new genes (http://www.embl-
heidelberg.de/info/sage/).   This method gives us a global view of the expression levels of 
every transcribed gene in a given sample. 
 Genes that are most differentially expressed between tachyzoites and bradyzoites 
are encoded into proteins that fall primarily into three functional groups: (1) stage-
specific surface proteins, (2) regulatory and metabolic enzymes, and (3) secretory 
proteins.  One important difference between tachyzoites and bradyzoites is the variety of 
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surface proteins that are expressed in a stage-specific manner [25]. Three SAG1 related 
surface antigens are highly expressed in bradyzoites compared to tachyzoites; SRS9 
(Ctoxoqual contig 4130) [24], SAG2C/D (Ctoxoqual contig 4135), and BSR4 [24].  Two 
other genes, (cyst matrix antigen) MAG1 and a mucin domain-containing (Ctoxoqual 
contig 3897), are expressed in tachyzoites but expression is significantly increased under 
bradyzoite conditions [24].  MAG1 encodes a cyst matrix antigen and the mucin domain-
containing protein may provide a protective barrier for bradyzoite cysts against the 
degradative enzymes within the gut due to the property that mucin domains are highly 
glycosylated [24].  The mucin domain-containing protein may also play a role in 
bradyzoite invasion since its homologue in the Apicomplexan, Cryptosporidium parvum, 
in known to be involved in host cell invasion [26].  
 There are three regulatory enzymes involved in metabolism that are highly 
upregulated in bradyzoites; methionine aminopeptidase (MAP) (Ctoxoqual contig 4080), 
oligopeptidase (Ctoxoqual contig 1284), and a gene that encodes a protein that has 
homology to class II pyridoxal phosphate-dependent aminotransferases (Ctoxoqual contig 
4095) [24].  MAP may regulate protein synthesis during the tachyzoite to bradyzoite 
transition by cleaving the N-terminal methionine of nascent proteins and may also be 
involved in inhibiting the phosphorylation of the initiation factor 2a as seen in other 
eukaryotes [27].  The oligopeptidase may be involved in regulating bradyzoite-specific 
metabolic pathways much like bacterial oligopeptidases regulate lactose metabolism [28].  
It is known that class II pyridoxal phosphate-dependent aminotransferases are involved in 
many cellular processes including amino acid metabolism and sphingolipid synthesis [29] 
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and may be important in establishing and/or maintaining the bradyzoite cyst environment.  
In contrast, glucose-6-phosphate dehydrogenase (G6PD) (Ctoxoqual contig1694) is 
highly expressed in tachyzoites but is repressed in bradyzoites.  G6PD is an enzyme 
involved in initiating the pentose phosphate shunt which could represent an important 
regulatory mechanism for differences observed in sugar metabolism in tachyzoites 
compared to bradyzoites [24].  Also, a decrease in G6PD causes a shift in metabolism to 
gluconeogenesis and, thus, amylopectin synthesis [24] and consistent with this 
amylopectin granules can be visualized ~75 hours post bradyzoite induction [25]. 
 Lastly, some of the genes that encode proteins that localize to the specialized 
secretory organelles in Toxoplasma gondii are also transcriptionally regulated during 
stage conversion.  For example, nucleoside triphosphate hydrolase 1 (NTP1) (Ctoxoqual 
contig 4801) [30], and genes encoding dense granule proteins, GRA1 (Ctoxoqual contig 
619) and GRA5 (Ctoxoqual contig 1406), and the gene encoding the rhoptry protein, 
ROP1 (Ctoxoqual contig 20), are all repressed in bradyzoites compared to tachyzoites 
[24].  In their 2002 manuscript, Boothroyd et al., stated that “Genes whose transcript 
levels increase in bradyzoites represent promising targets for a reverse genetics approach 
to identifying genes essential for bradyzoite development through targeted disruption.” 
[24].  In our laboratory, we have performed whole genome microarray analysis for a time 
course in bradyzoite differentiation and have identified hundreds of genes (n = 788) 
whose transcript levels increase in bradyzoites (72h post induction) and therefore 
represent potential targets for reverse genetic studies in the future (unpublished data, P. 
Lescault). 
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 The process of bradyzoite differentiation involves regulation of the cell cycle rate, 
alteration of gene expression and reorganization of organelles.  During the transition, the 
nucleus relocates from a central position in tachyzoites to a posterior position in 
bradyzoites [31].  Whether or not the mitochondrion is active in bradyzoites is debatable 
since bradyzoites are widely considered to be the dormant form [32, 33].   Roos et al. 
2004, showed that the mitochondrion and endoplasmic reticulum have decreased activity 
in bradyzoites compared to tachyzoites but the architecture is unchanged [20].  They also 
showed that protein activity within the dense granules is higher in tachyzoites compared 
to bradyzoites.  However, in bradyzoites, dense granule proteins are secreted into the 
parasitophorous vacuole.  The micronemes are restricted to the apical end of the 
tachyzoites but are dispersed throughout the body of the bradyzoite [20].  Roos et al., 
2004, found no architectural differences in the rhoptries during differentiation [20].  
Amylopectin granules are found in bradyzoites (75 h post induction) and this observation 
indicates the changes in energy metabolism during conversion [20].  Interestingly, the 
apicoplast seems to disappear in mature bradyzoites over time (35-124 hours) [20].  Time 
lapse microscopy studies revealed three different mechanisms for the loss of the 
apicoplast: (1) failure of the apicoplast to divide during endodyogeny, remaining in the 
residual body and resulting in two daughters without an apicoplast, (2) only one daughter 
received the apicoplast, and (3) the apicoplast seemed to degenerate in the absence of 
division as evidenced by loss of DAPI staining [20].  Lastly, although bradyzoites show a 
clear decrease in cell growth compared to tachyzoites, they are remarkably motile.  They 
are able to escape the parasitophorous vacuole and invade an adjacent host cell without 
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disturbing the host cell.  This phenomenon is in stark contrast to the tachyzoites, which 
lyse the host cell rendering it dead.  Bradyzoites accomplish escape and reinvasion 
without switching to the tachyzoite form.  This unique bradyzoite-specific mechanism 
may be what allows them to form many tissue cysts with just one infection [20]   
1.5 Mutant screen and Preliminary Data  
 Matrajt et al. 2002, developed a genetic screen to isolate parasites unable to form 
bradyzoites in order to identify key genetic factors that are involved in the bradyzoite 
differentiation process (Figure 3) [34]. 
 
Figure 3. Strategy for isolating bradyzoite differentiation mutants.  
“A. Construction of the parental parasite line 7-1, harbouring a combined positive/negative 
selectable marker (HXGPRT) that is specifically induced under bradyzoite differentiation 
conditions.B. Selection strategy used to isolate parasites harbouring regulatory gene mutations. 
This study reports on the isolation of putative mutants defective in positive regulation of 
bradyzoite gene expression. HXGPRT OFF indicates resistance to 6-thioxhantine (6-TX) and 
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sensitivity to mycophenolic acid (MPA); HXGPRT ON is 6-TXS and MPAR.C. Strategy for the 
identification of bradyzoite differentiation mutants by insertional mutagenesis.” [34] 
 
First, a vector containing the selectable marker, hypoxanthine xanthine guanine 
phosphoribosyltransferase (HXGPRT), was placed under the control of a strong 
bradyzoite-specific promoter (pt7) (Unpublished promoter trap data, R. Donald and D. 
Roos).  HXGPRT is a purine salvage enzyme that is resistant to mycophenolic acid 
(MPA) but susceptible to 6-thioxanthine [35].  RH ΔHXGPRT/ΔUPRT, a type I strain, 
was used because inactivation of the HXGPRT gene made this strain appropriate for 
selection in the mutant screen and the UPRT deletion makes this strain sensitive to 
pyrmidine starvation under low CO2 conditions which allows for efficient induction of 
the tachyzoite to bradyzoite transition in vitro [36-38].   After transfection with the pt7-
HXGPRT vector, parasites were selected for MPA resistance under bradyzoite induction 
conditions (CO2 starvation) and 6-thioxanthine resistance under tachyzoite conditions 
(high CO2) resulting in the 7-1 parental parasite line (Figure 3A). 
 The rationale behind this screen was if mutagenesis of the parental line knocked 
out a positive regulator of bradyzoite formation, then the selectable marker, HXGPRT, 
would not be expressed and the drug 6-thioxanthine would kill all parasites that do 
express HXGPRT, therefore isolating only those parasites that have a positive regulator 
knocked out (Figure 3B).  Likewise, if the mutagenesis resulted in knocking out a 
negative regulator of bradyzoite formation then the HXGPRT would be expressed under 
both tachyzoite and bradyzoite conditions, but this study focused on positive regulator 
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knockouts.  MPA would be used to select for only those parasites that do not express 
HXGPRT.  
 Next, insertional mutagenesis was performed with a mutagenesis vector that 
confers resistance to prymethamine [37, 38].  Transfected parasites were treated with 
prymethamine to kill all parasites that did not receive the mutagenesis vector.  After host 
cell lysis, tachyzoites were inoculated onto a fresh monolayer of host cells (human 
foreskin fibroblasts) and placed under CO2 starvation conditions.  In order to isolate 
mutant parasites that were unable to switch to form bradyzoites, cultures were treated 
with prymethamine and 6-thioxanthine for 3 days.  Again, pyrmethamine treatment killed 
all parasites that did not receive the mutagenesis vector and 6-thioxanthine selected for 
parasites that did not express HXGPRT under bradyzoite conditions.  The parasites were 
then put under tachyzoite conditions to grow up the populations and this selection 
strategy was repeated 3 more times to enrich the populations (Figure 3C). 
 Two mutant parasites were generated in this initial screen, B7 and P11.  
Experimental assays showed that these mutants had growth defects under bradyzoite 
conditions.  They grew fast, similar to wild type tachyzoites, under bradyzoite conditions.  
Expression of HXGPRT and two known bradyzoite-specific markers (BAG1 and 
Dolichos lectin) were quantified in the mutant parasites under bradyzoite conditions (CO2 
starvation and alkaline conditions).  Mutants showed reduced expression of these two 
bradyzoite markers.  These results showed that the mutants, B7 and P11, are indeed 
bradyzoite differentiation mutants; they grow fast under bradyzoite conditions and have 
reduced expression of bradyzoite-specific markers under two different induction 
conditions.  It was important to look at two known bradyzoite-specific markers in 
addition to HXGPRT expression because it was possible that the mutants were only 
deficient in HXGPRT expression, which is not the case.  It was also important to test 
whether the mutant phenotype was specific for CO2 starvation conditions or if it was a 
more general effect.  Since these mutants are defective in forming bradyzoites under an 
additional induction condition, alkaline conditions (not used to generate the mutants), the 
mutants must have a more general defect in bradyzoite formation. 
 After this initial study, several additional bradyzoite differentiation mutants were 
generated (Figure 4) (unpublished data, B. Thompson).   
 
Figure 4. Seven bradyzoite differentiation mutants have been disrupted in distinct 
sites in the genome. 
The chromosome and position of the insertion site is shown for each mutant.  Annotation of the 
physically disrupted gene (or the gene closest to the insertion site) is shown.  **position 4328500 
for mutant 11P is a near approximation and is currently being confirmed. 
 
Since two features that distinguish bradyzoites from tachyzoites are (1) their difference in 
replication rates and (2) their differential gene expression, all mutants were assayed for 
replication rate and expression of bradyzoite-specific markers.  Replication rate was 
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assayed at 72h post induction and the number of parasites per vacuole was counted for all 
samples.  All seven mutants show an increase in replication rate compared to wild type 
after 72h of bradyzoite induction (unpublished data not shown, V. Patil). 
 Expression of two known bradyzoite-specific markers (BAG1 and Dolichos 
lectin) was measured in wild type and mutant parasites after 72h of bradyzoite induction 
(unpublished data, V. Patil) (Figure 5). 
 
Figure 5. Expression of bradyzoite-specific markers, BAG1 and Dolichos lectin, in 
wild type and mutants parasites after 72h of bradyzoite induction. 
Wild type (71) show differential expression of the two bradyzoite-specific markers.  Percentage 
of vacuoles that stained positive for the markers was measured.  BAG1 expression is shown in 
green and Dolichos lectin staining is shown in red. 
 
BAG1 is a major cytosolic antigen and Dolichos lectin binds to the cyst wall.  
Approximately 80% of wild type parasites induced expression of these bradyzoite-
specific markers, whereas the mutants showed significantly reduced expression.  
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However, 20-30% of mutant parasites do express these bradyzoite-specific markers 
indicating a degree of leakiness of the mutant phenotype (a small percentage of parasites 
in each mutant parasite line have the ability to form bradyzoites). 
1.6 The Affymetrix Toxoplasma gondii GeneChip 
 The ToxoGeneChip was designed such that a variety of expression analyses 
(whole genome, transcript discovery, alternative splicing, genotyping, etc.) could be 
achieved on a single chip and this ingenious design came from the efforts of A. Bahl, 
under the direction of D. Roos.  (This was a remarkable design, worthy of noting, 
especially when you consider that most microarray chips available today only allow for 
one type of analysis per microarray chip.)  Affymetrix manufactured the ToxoGeneChip 
by using photolithographic technology, which allows for the simultaneous production of 
millions of probes on one chip 
(http://www.affymetrix.com/technology/manufacturing/index.affx) (Figure 6).   
 Figure 6. Photolithographic design used to create the ToxoGene chip. 
The details of this technology are discussed in the text. 
 
In brief, a square quartz wafer (5” X 5”) is coated with a light sensitive chemical 
compound and then a mask is applied to the wafer.  Next, the wafer is subjected to light, 
which deprotects the spots that are exposed by the mask and a nucleotide solution 
containing adenine, thymine, cytosine, or guanine is added.  In the example above 
(Figure 6), a solution of thymine is added and will only couple with the hydroxyl groups 
that remain exposed by the mask.  The probes are 25 nucleotides (nt) in length, so this 
process is repeated 25 times.  Approximately 100 masks are required to produce one 
quartz wafer containing millions of 25 nt probes since each nucleotide addition requires 4 
masks (one for each of the 4 nucleotide solutions).  Once this process is completed, the 5” 
X 5” quartz wafer is cut up into several hundred individual microarray GeneChips 
(http://www.affymetrix.com/technology/manufacturing/index.affx).   
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 The ToxoGeneChip contains a total of 214,042 probes (97% of the chip), which 
include the following: ~49% for whole genome expression profiling, ~33% for 
transcript/SNP discovery, ~10% for genotyping (genetic markers, resequencing SNPs and 
EST based SNPs), ~5% controls (human, mouse, yeast, cat genes), 0.64% for apicoplast 
genes, and 0.11% for mitochondrial genes (ToxoDB).  For whole genome expression 
profiling, there are ~ 11 matched probes to each of ~8000 predicted genes in the 
Toxoplasma gondii genome and each probe alignment can be viewed in the genome 
browser section of ToxoDB (http://www.toxodb.org/toxo/home.jsp) (Figure 7). 
 
 
Figure 7. An example of the 11 probes aligned to a gene in the ToxoDB. 
This example shows the exact position of each of the 11 probes that are aligned to gene, 
49.m00018, as seen in ToxoDB. 
 
1.7 Summary of Main Results 
 Two important studies of the bradyzoite differentiation mutants will be discussed 
in this thesis: (1) the whole genome expression microarray analysis of seven bradyzoite 
differentiation mutants and (2) the characterization of the disrupted locus in mutant B7.    
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 In the microarray analysis study we describe 4 main results: (1) the expression 
profile of wild type parasites after 24h of induction (intracellular state) is different from 
the expression profile of wild type extracellular tachyzoites; (2) Mutant extracellular 
tachyzoites (5/7) show a different expression profile compared to wild type extracellular 
tachyzoites, while 2/7 mutant extracellular tachyzoites show similar expression to wild 
type extracellular tachyzoites; (3) after 72h of induction, mutant parasites show a similar 
expression profile to wild type 24h post induction; and (4) we have developed a method 
for identifying genes that differ most in expression levels across all samples.   
 Characterization of the disrupted locus in mutant B7 revealed 5 main 
observations; (1) a putative ncRNA (B41) was disrupted and its expression is 
developmentally regulated in wild type parasites but expression is reduced in mutant B7, 
(2) the expression of an adjacent EST 13803210 is affected in the mutant but 
overexpression experiments show that this EST is not a key player in the bradyzoite 
differentiation pathway, (3) luciferase assays show that B41 does not function in 
regulating the expression of EST 13803210, (4) B41 is alternatively polyadenylated into 
a short (1kb) and a large (2.2kb) transcript and (5) cosmid complementation of mutant B7 




CHAPTER 2: MICROARRAY ANALYSIS:  DISSECTING THE EXPRESSION 




 The goal of our research is to identify genes involved in the regulation of the 
tachyzoite to bradyzoite interconversion because the proteins encoded by these genes 
may serve as potential drug targets that could prevent bradyzoite formation or rid the host 
of a chronic infection.  As described in Chapter 1, the Matrajt laboratory used a genetic 
screen to isolate seven mutants that show defects in bradyzoite formation; increased 
replication rate and reduced expression of bradyzoite-specific markers under bradyzoite 
induction conditions.  I have focused this branch of my research on dissecting the 
expression profiles of these mutants using whole genome microarray analysis.  Each gene 
expression profile appears to fit, at a coarse level, into one of three states, which we name 
based on wild type samples harvested at times 0, 24, and 72 hours after bradyzoite 
induction: extracellular tachyzoites (WT0), intracellular low CO2 parasites (WT24), and 
bradyzoites (WT72).  We show that under tachyzoite growth conditions, extracellular 
mutant parasites (t = 0h) exhibit a significantly different expression profile from wild 
type, WT0 (t = 0h) (p < 0.001).  However, extracellular mutant parasites (t = 0h and 72h) 
show a strikingly similar expression profile to WT24 (p < 0.02).  These results suggest 
that the mutant parasites are ‘stuck’ in a WT24-like (intracellular) state even when they 
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are extracellular and that there may be a commonality of regulation when switching from 
state to state.  Lastly, we have developed a method to identify genes that differ most in 
expression levels across all samples, which may allow us to order the mutants along the 
bradyzoite induction pathway, as well as provide candidate target genes for further 
studies on bradyzoite differentiation.  
2.1 Introduction: Microarray Analysis  
2.1.1 Experimental Design. 
 The whole genome microarray experiment was designed to evaluate the 
expression profiles of mutant and wild type parasites under tachyzoite and bradyzoite 
induction conditions in order to better understand how the disrupted loci in the mutants 
affect bradyzoite formation.  Freshly egressed extracellular tachyzoites were harvested 
for the tachyzoite samples (t = 0h) and parasites subjected to bradyzoite induction 
conditions for 72h were harvested for the bradyzoite samples (t =72h).  At the time of the 
experimental design it was assumed that there were little to no differences between 
extracellular and intracellular tachyzoites, therefore extracellular tachyzoites were used as 
the tachyzoite sample in order to avoid host cell contamination during the sample 
preparation (personal communication from M. Matrajt and D. Roos).  (Toxoplasma 
gondii is an obligate intracellular parasite, therefore host cell RNA contamination of 
parasite RNA samples is an important concern and the details of how we addressed this 
concern in the current study will be discussed in the last chapter). 
 When we originally compared the expression profiles of mutants and wild type, 
we were surprised to find that there were hundreds of genes in the mutants that behaved 
similarly to wild type.  We expected that most genes in the mutants would not respond to 
bradyzoite induction conditions and that a few genes would respond similar to wild type.  
If this were the case then we would be able to identify that a particular mutant was 
blocked in the bradyzoite differentiation pathway just upstream from the responsive 
genes (Figure 8).   
 
Figure 8. Differential gene expression plots show an example of what we expected to 
observe (left) compared to what we actually observed (right top-Mutant 13P; right 
bottom-Mutant B7). 
Wild type differential gene expression (under bradyzoite conditions compared to under tachyzoite 
conditions) is shown on the x-axes and mutant differential gene expression is shown on the y-
axes.  Details of the significance of this figure are discussed in the text. 
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Since we did not observe the expected scenario, we had to apply additional methods for 
analysis and these will be discussed in the Results section. 
 During our preliminary analysis, we contemplated the idea that these mutants may 
be delayed in forming bradyzoites and if we were able to lengthen the induction time then 
we may see bradyzoite formation of the mutants.  Because it was technically impossible 
to lengthen the induction time much past 72h due to host cell stress and death, we chose 
to do microarray analysis on a time course to address this hypothesis.  We performed a 
bradyzoite induction time course with wild type parasites only and harvested at 24h, 36h 
and 48h post-induction.  (If the mutants were delayed in forming bradyzoites then we 
might have observed that the expression profile for a mutant after 72h induction may be 
similar to the expression profile of the wild type after only 24h of induction and this was 
not the case.)  An overview of the entire experimental design is illustrated below (Figure 
9). 
 




Caveat lector. For simplicity and clarity throughout this thesis, we will refer to our 24h 
time point as “intracellular low CO2 parasites”, in order to account for the fact that we 
cultured these parasites under bradyzoite induction conditions but their expression profile 
matches to a great extent to ‘true’ intracellular tachyzoites (cultured under tachyzoite 
growth conditions, ie., high CO2) (unpublished data, D. Roos and A. Bahl, and analysis 
of data shown in section 4.1, J. Bond and P. Lescault).  Because our experimental design 
dictated that we use freshly egressed extracellular tachyzoites as time 0h rather than 
intracellular tachyzoites 24h post invasion, we have missed important biological events 
(host cell invasion, intracellular replication as tachyzoites before sensing the signal to 
switch to bradyzoites, etc.) and, thus, gene induction patterns along the differentiation 
pathway in our time course (Figure 10).  
 Figure 10.  Using extracellular tachyzoites as time 0h in our bradyzoite induction 
time course prevented observation of important gene expression changes between 0h 
and 24h resulting in the 24h sample showing a combination of the gene expression 
changes. 
Using intracellular tachyzoites (D. Roos laboratory experimental design) allows for observation 
of intracellular tachyzoite state (0h), early bradyzoite state (exclusively), and bradyzoite state 
gene patterns.  In contrast, using extracellular tachyzoites as time 0h prevented the observation 
that there is a distinction between genes represented by the intracellular tachyzoite (24h) and 




We have designed a new experiment to address this issue (results pending) and the details 
of this new experimental design will be discussed in the last chapter.  For the remainder 
of the thesis, we will refer to the 24h time point (WT24) as “intracellular low CO2 
parasites”. 
2.1.2 Expression statistics (E) relate to intensity (I)  
 
 Iij  ∝  RNAij  
 The intensity for probe set, i, of sample, j, is proportional to the RNA 
concentration for probe set, i, of sample, j (Figure 11). 
 
Figure 11. A schematic of the details of how expression statistics relate to intensity. 
 
 31
In brief, total RNA is extracted from the parasite sample and reverse transcribed into 
cDNA.  Next, the cDNA is in vitro transcribed into cRNA and then the cRNA is 
fragmented and hybridized to the affymetrix ToxoGeneChip.  A pixeled image of the 
hybridized chip is produced and probe intensities for each set of pixels is calculated using 
a statistical algorithm software program.  Next, the background is adjusted and a quantile 
normalization and summarization of the probe intensities is performed in order to 
produce the probe set intensity.    
 I :  i ⊗  j |→  0,∞[ ]  
The intensity for a given probe set (I) is based on probe set, i, of sample, j, and is inferred 
to be a positive value between zero and infinity.  A normalization step at this point in the 
analysis includes a background correction and a scaling correction and is important for 
accounting for two types of potential errors.  Background correction will account for chip 
to chip variation where, 
 Iij = Iik + Δjk  
j and k represent two different microarray chips and delta accounts for the differences in 
the properties of these two chips.  The scaling correction accounts for errors such as a 
pipeting error where, 
 Iij =  Iik αjk  
if, α = 2, then the chip, j, may have received 2X more RNA sample than chip, k.  This 
equation is equivalent to,  
 Eij = Log2αjk + Eik  
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where, the log of the product is equal to the sum of the logs.  Finally, the expression 
statistic (E) is equal to the log base 2 of intensity (I).   Analyzing microarray data in terms 
of E rather than I is the preferred convention since I values would not include zero, 
hence, making the plots conceptually harder to comprehend. 
 E =  Log2 I ∴  2E =  I  
2.2 Results 
2.2.1 Each mutant displays a unique whole genome expression profile and the 
differential expression plots (DE plots) illuminate three distinct properties of the 
mutants compared to wild type. 
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 Mutants were analyzed for whole genome expression differences as compared to 
wild type parasites in order to identify gene(s) that contribute to the mutant phenotype.   
Each parasite line was cultured under tachyzoite growth conditions (high CO2), 0h, or 
CO2 starvation conditions for 72 hours (bradyzoite induction conditions) and then 
subjected to microarray hybridization and analysis.  The DE plots allow us to visualize 
which gene(s) behave like wild type and which gene(s) differ in expression levels 
compared to wild type.  DE plots for each mutant versus wild type show a unique whole 
genome expression profile and allow us to visualize three distinct properties of the 
mutants: (1) genes that respond similarly to wild type under inductions, (2) genes that do 
not respond similarly to wild type under induction conditions (72h), and (3) the degree of 
leakiness.  Genes that behave similarly to wild type (feature 1) plot along the diagonal 
line (black) and genes that do not respond (feature 2) to bradyzoite induction conditions 
plot along the horizontal line (black) (Figure 12). 
 Figure 12. Differential gene expressionplots for wildtype versus each mutant. 
 
 For clarity, the DE plots of two mutants (B7 and 13P) will be used to discuss the 
features illuminated by these plots (Figure 13).    
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Figure 13. DE plots for wildtype versus mutant B7 (left) and wild type versus 
mutant 13P (right). 
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The details of these DE plots are discussed in the text. 
 
Gene expression levels of wild type bradyzoites (B) minus gene expression levels of wild 
type tachyzoites (T) are plotted along the x-axis.  For wild type parasites, the genes that 
are up-regulated ≥ 2 fold after 72h bradyzoite induction compared to extracellular 
tachyzoites (0h) have an expression value ≥ 1 (B-T ≥ 1), which corresponds to a fold 
change value ≥ 2 (B/T ≥ 2).  These genes are encircled with a black oval on the x-axis 
and represent bradyzoite up-regulated genes.  The expression levels of mutant 
bradyzoites (B) minus mutant tachyzoites (T) are plotted on the y-axis for each mutant.  
Again, for mutant parasites, the genes that are up-regulated ≥ 2 fold after 72h bradyzoite 
induction compared to extracellular tachyzoites (0h) have an expression value ≥ 1 (B-T ≥ 
1), which corresponds to a fold change value ≥ 2 (B/T ≥ 2).   It is important to note that 
the extent to which bradyzoite up-regulated genes are expressed is quite different 
between wild type  (~2 - 256 fold change) and mutants (~2 - 8 fold change).  As 
illustrated in Figure 13, genes that are encircled by the green oval represent the genes that 
respond to bradyzoite induction conditions (72h) at a much lesser extent compared to 
wild type parasites.  These genes represent the leakiness of the mutants (feature 3) (a 
fraction of the mutant parasite populations do form bradyzoites) and the 
immunofluorescence assays of bradyzoite-specific markers (Figure 5) show this as well. 
 When we look at the DE plots of all mutants (Figure 12), we observe that 
mutants, B7, 11K, 11P, 7K and P11, show little or no response to low CO2  (72h) (genes 
that cluster along the black horizontal line), while mutants, 12K and 13P, show a split 
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(sideways “Y” shaped line) in their gene expression pattern, where a subset of genes 
respond similarly to wild type and a subset of genes do not respond to CO2 starvation 
(72h).  
2.2.2 The wild type time course for bradyzoite induction suggests a great difference 
in gene expression between extracellular parasites and intracellular low CO2 
parasites. 
 We performed a bradyzoite induction time course with wild type parasites and 
analyzed the whole genome expression profiles at the following time points: 0h 
(extracellular tachzyoites), and 24h, 36h, 48h, and 72h post-bradyzoite induction.  Genes 
that were upregulated ≥ 2 fold at 72h compared to 0h (n = 788) clustered into three 
distinct subsets; early genes (n = 356), middle genes (n = 183), and late genes (n = 249) 
(Figure 14A).   
 
Figure 14. Bradyzoite up-regulated genes cluster into three distinct patterns. 
 
The first subset of genes (early gene cluster) is expressed at 24h post bradyzoite induction 
(n = 356) and significantly induce from 0h to 24h, remain highly expressed 24h-48h, and 
then begin to decrease at 72h post bradyzoite induction.  The second subset of genes 
(middle gene cluster) is moderately induced from 0h to 24h, remain steady 24h-48h, and 
then increase expression at 72h post-induction (n=183).   The third subset of genes (late 
cluster) are induced between 48h and 72h post bradyzoite induction ( n = 249 ) and are 
repressed from 0h to 48h. 
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2.2.3 Bradyzoite differentiation mutants are ‘stuck’ in the intracellular low CO2  
state (WT24) even though they are extracellular. 
 When we look at the expression profiles of the mutants in the context of the wild 
type bradyzoite induction time course we see that 5/7 of the mutants are ‘stuck’ in the 
intracellular low CO2 parasite state (Figure 14B).  State modeling is a statistical method 
that involves segregating all samples into the state with which they most closely belong 
to based on the frequency of the gene expression patterns observed for each sample at 
each time point.  This method quantitatively describes the phenomenon that we see by 
eye; mutants are ‘stuck’ in an intracellular low CO2 parasite state (state modeling data not 
shown, J. Bond).  Wild type parasites induce the intracellular low CO2 subset of genes at 
24h post bradyzoite induction (early genes) as compared to 0h (extracellular tachzyoites) 
but some of the mutants already have these genes on at time 0h and 72h.  These early 
genes appear to represent the gene expression profile of an intracellular tachyzoite (see 
Figure 10 for clarity).  Interestingly, this phenomenon is only seen in 5/7 mutants (B7, 
11K, 11P, 7K and P11), while the other 2 mutants (12K and 13P) behave like wild type 
for this subset of genes.  Wild type parasites moderately induce a subset of genes between 
24h-48h (middle genes) and then the expression significantly increases by 72h.  The 
middle genes appear to represent those genes involved in the transition from tachyzoites 
to bradyzoites and respond to low CO2  (please refer to Figure 10 for clarity). Lastly, wild 
type parasites significantly induce a subset of genes between 48h-72h (late genes) and 
this subset of genes is not induced in any of the mutants.   
2.2.4 Wild type and mutant extracellular tachyzoites show significantly different 
expression profiles, but mutant extracellular tachyzoites look similar to wild type 
intracellular low CO2 parasites. 
 A contingency table comparing whether each replicate, for each sample, behaves 
more like extracellular tachyzoites or intracellular low CO2 parasites illustrates two 
distinct results: (1) extracellular wild type parasites have a different expression profile 
from extracellular mutant parasites (p < 0.001) and (2) extracellular mutant parasites have 
an expression profile that is significantly similar to wild type low CO2 parasites (24h) (p 
< 0.03) (Figure 15).  
 
Figure 15. A contingency table showing that extracellular wild type and mutants are 
different but extracellular mutants are similar to wild type intracellular low CO2 
parasites.   
The parasite lines are listed in the first column.  The second column shows how many replicates, 
for each sample, behave more like extracellular tachyzoites (left of slash) or intracellular low CO2 
parasites (right of slash), at time 0h.  The third column shows how many replicates, for each 
sample, behave more like extracellular tachyzoites (left of slash) or intracellular low CO2 
parasites (right of slash), at time 72h. 
 
We can also connect the corresponding biology of each state based on the genes that are 
represented in each state.  For example, genes involved in DNA replication and the cell 
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cycle are present in both extracellular tachyzoites and intracellular low CO2 parasites 
(early genes), but are not represented by the middle genes of intracellular low CO2 
parasites (genes that appear to represent early bradyzoites) (Figure 16).   
 
 
Figure 16.   DNA replication and cell cycle genes segregate into the different states 
based on the relevant biology of each state. 
 
Extracellular tachyzoites and bradyzoites arrest their cell division while intracellular 
tachyzoites are actively replicating.  It is important to note that although DNA 
replication/cell cycle genes are represented in the extracellular tachyzoite state, they do 
not appear to represent an actively replicating parasite. The extracellular tachyzoites 
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express genes involved in DNA repair and the regulation of progression through the cell 
cycle.  For example, cullin belongs to a family of proteins that are involved in negative 
regulation of the cell cycle.  While the ‘early’ genes represented by the intracellular low 
CO2 parasites show clear trademarks of active DNA replication, the ‘middle’ genes 
represented by the intracellular low CO2 parasites exhibit no DNA replication/cell cycle 
genes.  Again, the mutants are ‘stuck’ in an intracellular low CO2 parasite state and thus 
are expressing a gene profile representative of actively replicating parasites even though 
the mutants are extracellular. 
2.2.5 R Score Analysis and the identification of genes that show the most variation 
in expression levels across all samples. 
 The R score is a statistic that helps us to identify those genes that express most 
differently across all samples and all time points.  We are interested in identifying these 
genes because they are likely to represent those genes involved in the mechanism of the 
transition and will serve as candidate target genes for further study.  The rationale behind 
this idea includes several key points: (1) we know that the mutants have been generated 
by insertional mutagenesis which disrupted a single locus in each mutant leading to 
defects in bradyzoite formation, (2) we know that each mutant has been disrupted at 
distinct positions in the genome and (3) each mutant displays a unique whole genome 
expression profile (albeit, with some common themes).   Genes that behave similar 
among samples most likely represent the genes that are either upstream or downstream 
from the block in bradyzoite formation.  For example, a subset of genes that are similar 
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among all mutants may be genes that do not allow appropriate arrest in the cell cycle and 
thus will remain upregulated in the mutants (these genes may represent genes upstream in 
the bradyzoite differentiation cascade).  Genes that express similarly in all samples, 
including wild type, may represent end state bradyzoites (reflecting the leakiness of the 
mutants).  Again, these genes are uninteresting and reflect genes that are downstream 
from the block in bradyzoite formation.  Most interesting, are those genes that vary most 
among samples and are the genes that lie within the range of the cascade in which 
transition can be blocked.  Given that we have several distinct mutants to compare, it 
would be interesting to see which of the most varied genes (highest R scores) are similar 
or different among different mutants.  Not only could these genes serve as candidate 
genes for further study of the differentiation pathway but we could also use these genes to 
dissect the order of which mutants were disrupted in which place along the transition.  
Unfortunately, the details of these analyses will not be discussed here because complete 
analysis of these hypotheses go beyond the scope of the current study.   
 The top 3 genes that have the highest R scores are: R=7807 (551.m00236-
hypothetical), R= 1109 (44.m02759- supt5h), and R= 520 (113.m00800- DNA primase) 
(Figure 17). 
 Figure 17. The residual values for genes with the highest R scores. 
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Residual values represent how different the observed expression of a given gene differs from the 
expected expression (based on wild type state modeling).  A residual value close to 0 means that 
the expected value is similar to the observed value.  Gene 551.m00236 is highly expressed in 
mutant 7k compared to all other samples (yellow).  Gene 44.m02759 is also highly expressed in 
mutant 7K compared to all other samples (red).  And, gene 113.m00800 is highly expressed in all 
samples except for mutant B7, mutant P11 and wild type. 
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Supt5h is a subunit of a complex involved in repressing transcription elongation (Bethyl 
Laboratories, Inc.).  DNA primase is one of the large subunits that comprises the alpha 
DNA polymerase:DNA primase complex.  This complex catalyzes the synthesis of an 
RNA primer on the lagging strand of replicating DNA (ToxoDB).   
2.3 Methods 
RNA Isolation. 
Total RNA was extracted from parasites that had freshly lysed the host cells, extracellular 
tachyzoites, or 72h post induction bradyzoites.  Infected monolayers were scraped, 
dounce homogenized and filtered through a 3micron filter (Millipore).  Parasites were 
centrifuged and washed 2 times with 1X phosphate buffered saline (PBS) in DEPC water.  
Pellets were resuspened in lysis buffer RLT (Qiagen) and passed through a 26G needle.  
Finally, samples were processed through the RNA mini kit (Qiagen) and DNase treated 
on the column.  (Elution with 50°C RNase-free water increased our yield).  RNA 




 Our data strongly suggest that the expression profile of wild type extracellular 
tachyzoites (t=0h) is significantly different from the expression profile of intracellular 
low CO2 parasites (t=24h), which demystifies the assumption in the Toxoplasma research 
community that parasites grown under tachyzoite growth conditions are all the same 
whether or not they are actively replicating intracellular tachyzoites or ‘freshly’ egressed 
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extracellular tachyzoites.  This result has important implications for future experimental 
design in our own laboratory as well as other interested laboratories in the Toxoplasma 
research community.  It is now clear that the tachyzoite state can be broken up into two 
distinct states, the extracellular tachyzoite state in which parasites are outside of the host 
cell, presumably poised to survive by invading a new host cell or to die, since they are 
obligate intracellular parasites.  Once the parasites have invaded the host cell they 
transition to the intracellular tachyzoite state where they rapidly replicate and then lyse 
the host cell, at which point they transition back to the extracellular state (if left for some 
yet to be determined time period without an opportunity to invade another host cell). 
 Some extracellular mutants (B7, 11K, 11P, 7K and P11) show a different 
expression profile compared to wild type extracellular parasites under both high CO2 
(t=0h) and low CO2 (t=72h), but interestingly, these mutant extracellular parasites have 
expression profiles that are strikingly similar to wild type intracellular low CO2 parasites.  
In contrast, the other two mutant parasite lines (12K and 13P) show a similar expression 
profile as wild type extracellular parasites under high CO2, but look like wild type 
intracellular low CO2 parasites after 72h of induction.  This result suggests that there is a 
commonality of regulation in switching from state to state.  Mutants B7, 11K, 11P, 7K 
and P11 are not only defective in switching to the bradyzoite state (72h) (they get ‘stuck’ 
in the intracellular low CO2 parasite state) but they can’t switch to the extracellular 
tachyzoite state either (0h).  Interestingly, mutants, 12K and 13P, also get ‘stuck’ in the 
intracellular low CO2 parasite state after 72h of induction and cannot form bradyzoites, 
but these mutants are able to switch to the extracellular tachyzoite state under high CO2 
(0h).    
 We propose a working model to explain where the mutants are blocked along the 
bradyzoite differentiation pathway (Figure 18). 
 
Figure 18. A working model. 
 
Figure 18A describes an oversimplified pathway for the tachyzoite to bradyzoite 
transition.  Tachyzoites sense a stress signal and then the transition to bradyzoites is 
initiated, where the cell cycle slows down and bradyzoite-specific genes are induced.  
Figure 18B illustrates the tachyzoite to bradyzoite transition in the context of what we 
learned from our microarray analysis.  Gene expression levels for early, middle and late 
genes are shown for each state along the transition for which we have data.  Extracellular 
parasites induce early genes, perhaps after sensing an environment containing host cells.  
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Extracellular parasites invade host cells and radiply replicate until they lyse the host cell 
during egress and will either invade new host cells or initiate transition upon sensing a 
stress signal.  Upon initiation of the transition, early gene expression levels reduce and 
cell cycle arrest occur.  (Genes that represent actively replicating parasites are 
represented in the early gene cluster).  Middle genes are induced and then late genes are 
induced and this gene induction results in the formation of bradyzoites.  We hypothesize 
that two events, cell cycle arrest and sensing an extracellular signal, are required to enter 
into the extracellular tachyzoite state represented by repression of early, middle and late 
genes.  Additionally, cell cycle arrest and sensing a stress signal are the two events 
required for entering into the brdayzoite state.  Mutants B7, 11K, 11P, 7K and P11 are 
‘stuck’ in the intracellular state, represented by early gene induction, at time = 0h and 72h 
post induction.  This result suggests that these 5/7 mutants are in some way defective in 
cell cycle arrest and cannot enter into the extracellular state, represented by repression of 
early middle genes, nor can they enter into the bradyzoite state.  Mutants 12K and 13P 
can enter into the extracellular state, represented by repression of early, middle and late 
genes, at time = 0h, but are ‘stuck’ in the intracellular state, represented by early gene 
induction, after 72h post induction.  This result suggests that these two mutants are, in 
some way, defective in sensing the stress signal and cannot enter into the bradyzoite state.  
However, these two mutants can enter into the extracellular tachyzoite state, represented 
by repression of early, middle and late genes, so they are not defective in cell cycle arrest 
and sensing the extracellular signal. 
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 Radke, et al., 2005, performed analysis on SAGE libraries that were created for 
nine different time points during development of Toxoplasma gondii in order to better 
understand the molecular basis of the developmental switch during bradyzoite 
differentiation [40].  5/9 of the libraries analyzed consisted of a developmental time 
course of in vitro sporozoite to bradyzoite differentiation.  These five libraries included; 
oocysts containing mature sporozoites, emerging parasites 4 days post inoculation with 
the mature sporozoites, rapidly growing parasites 6 days after inoculation with infectious 
sporozoites, intracellular parasites 7 days after inoculation with infectious sporozoites 
(and 24h post bradyzoite induction- alkaline conditions), and slowly growing parasites 15 
days after inoculation of infectious sporozoites (and 266h post bradyzoite induction).  
Radke et al., 2005, also analyzed 4 other SAGE libraries that included 3 intracellular 
tachyzoite timepoints (TypeI-RH, TypeII-Me49B7 and TypeIII-Vegmsj) and a 72h post 
bradyzoite induction time point for a TypeII strain (Vegmsj) [40].   
 We can make comparisons between the Radke et al., 2005 study and our 
microarray analysis.  Again, the time points in our wild type parasite time course 
included; extracellular tachyzoites (0h), and 24h, 36h, 48h and 72h post bradyzoite 
induction (CO2 starvation) for the TypeI RH strain.  We report that our 24h post 
induction time point includes a mixture of rapidly growing intracellular tachyzoites and 
transitioning parasites (due to our experimental design in which we used extracellular 
tachyzoites as our time 0h we are able to see the gene expression patterns for both rapidly 
growing tachyzoites (represented by early genes) and transitioning parasites (represented 
by middle genes) in our 24h sample).  Despite the strain and bradyzoite induction 
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condition differences between our study and the Radke et al., 2005 study, we can draw 
parallels in the observations of both studies.  Radke et al., 2005, show that day 6 
(intracellular parasites 6 days after sporozoite inoculation and 48h post invasion of 
‘emerging’ parasites) parasites induce expression of genes that indicate active nuclear 
replication and cell division compared to day 7 (intracellular parasites 7 days after 
sporozoite inoculation, 72 after invasion with ‘emerging’ parasites and 24h post 
bradyzoite induction) parasites [40].  This observation is consistent with our observation 
of our 24h post induction sample, where the early genes in this sample represent actively 
replicating parasites but the middle genes in this sample show reduced expression of 
genes indicative of a rapidly growing parasite.  Thus, both studies show that gene 
expression in parasites that have been exposed to bradyzoite induction conditions for 24h 
show reduced replication.  These observations are not surprising since it has been well 
established that one of the key features that distinguish tachyzoites from bradyzoites is 
growth rate.  Therefore, we expected to see replication-related genes induced in 
intracellular tachyzoites compared to parasites that have been exposed to bradyzoite 
induction conditions.   
 In addition to the intracellular parasites (with and without exposure to induction 
conditions) showing differential expression of replication-related genes, we also observed 
an interesting expression pattern in extracellular parasites.  In our microarray study we 
observed that extracellular tachyzoites show reduced expression of replication-related 
genes compared to 24h post induction (representing rapidly growing tachyzoites-early 
genes and transitioning parasites-middle genes).  Radke, et al., 2005 analyze a sample of 
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parasites that are ‘emerging’ 4 days after inoculation with sporozoites and they observe 
that this sample (day 4) has reduced expression of cell growth-related genes.  It is 
important to note that the Radke et al., 2005 ‘emerging’ parasites are of sporozoite origin, 
where as, our ‘freshly’ egressed parasites are tachyzoites. 
 Interestingly, we observe the induction of known bradyzoite markers (ie., BAG1) 
after 24h of bradyzoite induction, whereas Radke et al, 2005, do not observe induction of 
‘mature’ bradyzoite markers (ie., BAG1) in their day 7 sample (intracellular parasites 7 
days after sporozoite inoculation, 72h post invasion of ‘emerging’ parasites and 24h post 
bradyzoite induction).  However, Radke et al., 2005, do observe BAG 1 induction in their 
72h post bradzyoite induction sample (Vegmsj).  Their studies also show that 72h post 
induction reveals a more mature bradzyoite compared to 15 days post sporozoite 
inoculation.  This result suggests that in vitro differentiation from sporozoite to 
bradzyoite is less efficicient compared to in vitro differentiation between intracellular 
tachyzoite to 72h post bradyzoite induction differentiation [40].  The difference in strain 
and induction conditions could account for the discrepancies between our study and the 
Radke et al., 2005, study in regards to BAG1 expression. 
 In conclusion, the results from our microarray studies have the following 
implications: (1) the mutants break into two distinct families where mutants 12K and 13P 
have been disrupted in such a way that they can still sense their environment (high CO2) 
and alter their gene expression accordingly, whereas mutants B7, 11K, 11P, 7K and P11, 
cannot sense their environment and therefore do not alter their gene expression 
(perpetually ‘stuck’ in an intracellular low CO2 state), or (2) there is a technical issue 
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with the experimental design in which extracellular parasites were harvested during a 
range of time resulting in some parasites (B7, 11K, 11P, 7K and P11) not being outside 
of the host cell long enough to show alterations in their gene expression (we have 
designed additional experiments to rule out this latter possibility and the details of those 





CHAPTER 3: CHARACTERIZATION OF BRADYZOITE 




Bradyzoite differentiation mutant B7 was generated by Matrajt et al., 2002, as described 
in Chapter 1.  I have focused this branch of my research on the characterization of the 
disrupted locus in this mutant.  The insertional mutagenesis vector (described in section 
1.5) disrupted a putative non-coding RNA that was isolated from a bradyzoite cDNA 
library, contains no substantial open reading frame, and is developmentally regulated.  
B41 becomes induced under bradyzoite induction conditions in wild type but expression 
is reduced in the mutant.  B41 is alternatively spliced into a short (1.0kb) and long 
(2.2kb) transcript.  An EST (13803210) that is located just downsteam from the insertion 
site was isolated from a tachyzoite cDNA library and its expression remains induced in 
the mutant under bradyzoite conditions.  We performed overexpression experiments with 
EST 13803210 and determined that this EST is not a key player in bradyzoite formation.  
Because non-coding RNAs are known to play a role in transcriptional regulation in other 
species we used a luciferase reporter assay to test if B41 regulates the expression of EST 
13803210 and it does not.   Finally, we were able to complement the mutant phenotype 





 Plasmid rescue and inverse PCR were previously performed on mutant B7 
genomic DNA in order to identify the locus that had been disrupted during insertional 
mutagenesis (unpublished data, M. Matrajt).  The insertional mutagenesis vector 
integrated into the 3’ end of a putative non-coding RNA gene (B41) that was isolated 
from a bradyzoite cDNA library and contains no substantial open reading frame (ORF).  
Immediately downstream from the mutagenesis vector there is an EST (13803210) that 
was isolated from a tachyzoite cDNA library and has no homology to any known genes 
(Figure 19A, unpublished data, M. Matrajt).   
 
Figure 19. Genomic location of the insertional mutagenesis vector in mutant B7 and 




A. The insertion integrated into the 3’ end of B41 and just upstream from EST 13803210. B. RT-
PCR for wild type (WT) and mutant B7 (M) under tachyzoite (T) and bradyzoite (B) induction 
conditions (72h post induction) was performed for the following genes; alpha-tubulin (strong 
constitutive gene used as a loading control), enolase I (known bradyzoite-specific gene used as a 
positive control of bradyzoite induction), B41 and EST 13803210. 
 
A non-quantitative reverse transcriptase polymerase chain reaction (RT-PCR) was 
performed in order to investigate the expression levels of B41 and EST 13803210 
(unpublished data, M. Matrajt) (Figure 19B).  Samples were measured from both wild 
type and mutant parasites under tachyzoite (‘freshly’ egressed extracellular tachyzoites) 
and bradyzoite (72h post bradyzoite induction) conditions.  The strong constitutively 
expressed gene, alpha-tubulin, was run as a positive control to normalize loading of each 
sample and its expression profile is shown in the first panel of Figure 19B.  Enolase I, a 
known bradyzoite-specific gene, shown in the second panel, was run as a positive control 
of bradyzoite induction.  Note that enolase I expression is only detected in samples that 
were subjected to bradyzoite induction conditions (72h) and is not present in samples 
grown under tachyzoite conditions.  The expression profile of B41 is shown in the third 
panel and expression is only detected in wild type parasites grown under bradyzoite 
induction conditions, confirming that it is a bradyzoite-specific gene.  However, 
expression of B41 is lost in the mutant under bradyzoite induction conditions, which is 
consistent with the result that this gene is physically disrupted in the mutant.  The fourth 
panel of Figure 19B shows the expression profile of EST 13803210 but, because the 
method used in this experiment was a non-quantitative RT-PCR, it is ambiguous whether 
the small differences seen in this panel are significant.  When I began my research in the 
Matrajt laboratory, I continued with the characterization of the disrupted locus in the 
bradyzoite differentiation mutant, B7. 
3.2 Results 
 
3.2.1. B41, a bradyzoite-specific gene, shows reduced expression in the mutant and 
EST 13803210, a tachyzoite-specific gene, does not get down-regulated under 
bradyzoite conditions in the mutant. 
 A quantitative RT-PCR was performed on B41 and EST 13803210 in order to 
confirm the previous non-quantitative RT-PCR results and to obtain a quantitative 
measure of the expression profiles of EST 13803210 (Figure 20). 
 
Figure 20. Quantitative RT-PCR of B41 and EST13803210 in wild type and mutant 
parasites under both tachyzoite and bradyzoite conditions. 
 





RNA was isolated from both wild type and mutant parasites under tachzyoite and 
bradyzoite conditions.  Analysis of B41 included a time course where we analyzed the 
expression profile of B41 under tachyzoite (T) (‘freshly’ egressed extracellular 
tachyzoites) and bradyzoite conditions (B-day 2 and B-day 4, post induction).  Analysis 
of EST 13803210 was performed in the same manner as the previous study where we 
analyzed the expression profile under both tachyzoite (T) and bradyzoite conditions (B) 
(72h post-induction).  The strong constitutive gene, alpha-tubulin, was used to normalize 
each sample.  The expression profiles of B41 are shown in the left panel and each sample 
is expressed as a value relative 1.0, where wild type under tachyzoite conditions was 
chosen to equal 1.0.  The expression of B41 in wild type parasites is significantly induced 
over time under bradyzoite induction conditions; 5.3-fold induction at day 2 and then 
24.6-fold induction at day 4 compared to expression under tachyzoite conditions.  
However, mutant B7 shows significantly reduced expression over time; 2.8-fold 
induction at day 2 and then 7.8-fold induction at day 4.  The expression profile of EST 
13803210 shown in the right panel of Figure 20 confirms that this gene is a tachyzoite-
specific gene with expression levels reduced 3-fold under bradyzoite conditions (72h 
post-induction) compared to tachyzoite conditions.  However, expression of EST 
13803210 is not down-regulated under bradyzoite conditions in the mutant.  In 
conclusion, B41 is a developmentally regulated gene whose expression is reduced in the 
mutant under bradyzoite induction conditions.  EST 13803210 is a tachyzoite-specific 
gene that gets down-regulated in wild type parasites under bradyzoite induction 
conditions but its expression remains on under both tachyzoite and bradyzoite conditions 
in the mutant.  
3.2.2 B41 is a large non-coding RNA (contains no ORF) that is alternatively 
polyadenylated. 
RACE, Rapid Amplification of cDNA Ends, is a method used to identify the full length 
of a transcript.  We used 5’ and 3’ RACE to identify the entire length of the B41 gene and 
determined that B41 is alternatively polyadenylated resulting in two large (1.0kb and 
2.2kb) transcripts (Figure 21). 
 
Figure 21. A schematic of the alternatively spliced products of the B41 gene. 
 
The details of this schematic are discussed in the text. 
 
We aligned the B41 sequences (1.0 kb and 2.2kb) to the Toxoplasma genome and the 
position of this gene is on chromosome VI: 66555..67494(1.0kb)/69155(2.2kb) and the 
insertion is located on chromosome VI at position 69000.  We also aligned the sequence 




3.2.3. The putative non-coding RNA, B41, does not regulate the expression of the 
EST 13803210. 
  We hypothesized that B41 is functioning as a non-coding RNA (ncRNA) 
involved in the regulation of gene expression during bradyzoite differentiation.  We know 
that in wild type parasites B41 gets upregulated and EST 13803210 gets down-regulated 
under bradyzoite induction conditions.  It is well documented in the literature that large 
ncRNAs that are developmentally regulated and polyadenylated play an important role in 
regulating the expression of other genes that are adjacent to the site of transcription of the 
large nc-RNA [39].  The ncRNAs regulate their neighboring genes by recruiting 
chromatin remodelers which results in silencing the adjacent genes at a single site, 
throughout the genomic region, or across the entire chromosome [39].  Since B41 is 
upregulated and EST 13803210 is downregulated in wild type parasites under bradyzoite 
conditions, we hypothesize that B41 is silencing the expression of EST 13803210 under 
bradyzoite conditions.  Because expression of B41 is lost in the mutant, it is unable to 
repress the expression of EST 13803210 and this may cause the mutant phenotype. 
 In order to test if B41 is silencing EST 13803210, two constructs were made: (1) 
the luciferase gene driven by the EST 13803210 promoter (pEST-LUC) and (2) the 
luciferase gene driven by the EST 13803210 promoter plus the entire B41 gene 
(including 1000bp upstream from the B41 transcription start site in attempt to include the 
entire B41 promoter) (B41-pEST-LUC).  If B41 does function in silencing the EST via 
its promoter then we would expect that transgenic parasites containing pEST-LUC will 
be able to express luciferase under both tachyzoite and bradyzoite conditions because 
B41 is not present to silence luciferase.  But, transgenic parasites expressing B41-pEST-
LUC will only express luciferase under tachyzoite conditions because B41 is able to 
silence luciferase expression (Figure 22A).   
 
Figure 22. Luciferase reporter assays show that B41 does not regulate EST 
13803210. 
A. The idea behind this experimental design is that under bradyzoite conditions B41 gets 
upregulated and EST 13803210 gets down-regulated.  We wanted to test the hypothesis that B41 
regulates the expression of EST13803210.  The two constructs used in this experiment are 
illustrated and the expected results are shown. B. Luciferase activity is represented as the fold 




Wild type parasites were transiently transfected with B41-EST-LUC or EST-LUC and 
subjected to bradyzoite induction conditions for 0h, 48h, 96h and 120h, and luciferase 
activity was measured in a luminometer.  Luciferase activity is represented as the fold 
difference of luciferase activity of the B41-EST-Luc parasites over the activity detected 
in the EST-LUC parasites.  A ratio of 1.0 would mean that both parasite lines were 
expressing the same amount of luciferase and thus, luciferase activity would be the same 
for each parasite line.  Both parasite lines expressed the same amount of luciferase under 
both tachyzoite (0H) and bradyzoite conditions (48H, 96H and 120H, post induction) 
(Figure 21B). This observation suggests that B41 is not silencing the EST.  However, 
until we take a closer look at the expression profiles of the other genes at this locus, we 
cannot rule out the possibility that B41 is affecting the expression of other genes in this 
locus (that may, in turn, influence the expression of EST13803210). 
3.2.4 B41 is the only gene within 100kb of the insertion that has its expression 
affected in mutant B7. 
 The gene expression levels of 16 genes within 100kb of the insertion site were 
analyzed using the whole genome microarray data in order to determine if the expression 
level of any of the other genes adjacent to the insertion were affected in mutant B7 
(Figure 23).  
 Figure 23. Expression has not been affected in any other gene within 100kb of the 
insertion. 
 
 Gene expression for wild type and mutant are represented by fold change of 
expression under bradyzoite conditions over expression under tachyzoite conditions for 
each gene.  A ratio value of 1.0 would mean that expression is unchanged between 
tachyzoites and bradyzoites.  There is no change in expression level between tachyzoites 
and bradyzoites in wild type or mutant B7.  B41 is the only gene within 100kb of the 
insertion that has been affected in the mutant (aside from EST 13803210 which we will 
address in the following section). 
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3.2.5. Overexpression analysis of EST 13803210 confirms that this gene does not 
play a key role in bradyzoite differentiation. 
 Wild type parasites express EST 13803210 under tachyzoite conditions and 
downregulate its expression under bradyzoite conditions. However, the mutant parasites 
are unable to downregulate the expression of EST 13803210 under bradyzoite conditions.  
It is possible that EST 13803210 must get down-regulated in order for the parasites to 
switch to the bradyzoite form.  Since EST 13803210 is not getting downregulated in 
mutant B7 under bradyzoite induction conditions, it is possible that this gene is causing 
the mutant phenotype.  In order to test this hypothesis, we overexpressed EST 13803210 
in wild type parasites and subjected these parasites to bradyzoite induction conditions 
with the expected result that these parasites would not be able to form bradyzoites if the 
hypothesis is correct (Figure 24A).  The rationale for this experimental design was that 
overexpressing EST 13803210 would mimic at least one aspect of the mutant phenotype 
in that this gene is not downregulated under bradyzoite conditions.  
 Wild type parasites were transfected with a construct containing EST 13803210 
under the control of the strong constitutive alpha-tubulin promoter and these parasites 
were selected with chloramphenicol to generate a stable transgenic line. The transgenic 
parasites were subjected to bradyzoite conditions and assayed for bradyzoite specific 
markers using immunofluorescence assay for a known bradyzoite surface antigen (4F8) 
and Dolichos lectin staining. The transgenic parasites expressed the same amount of 
bradyzoite specific markers under bradyzoite conditions as the wildtype parasites 
expressed (Figure 24B).   We also performed a quantitative RT-PCR (qRT-PCR) on wild 
type and transgenic parasites to confirm that EST 13803210 was indeed overexpressed in 
the transgenic parasite line.  The qRT-PCR showed that the transgenic line expressed 
EST 13803210 80-fold higher than wild type parasites (Figure 24C). 
 
Figure 24. Overexpression experiments show that EST 13803210 is not a key player 
in bradyzoite formation. 
A. Expected results are shown for wild type (WT), mutant B7, and transgenic parasites 
(overexpressing EST 13803210). B. Immunofluoresence assay for bradyzoite-specific markers, 
surface antigen (4F8) and Dolichos lectin.  The top panel shows one bradyzoite cyst stained with 
both markers under phase and fluorescence microscopy. The bottom panel shows the percentage 
of vacuoles that did not stain for the bradyzoite-specific markers (bradyzoite induction of wild 
type parasites is never 100%) for both wild type (WT 7-1) and transgenic parasites (7-1EST). C. 
qRT-PCR for expression of EST 13803210 in wild type (WT(7-1B-3) and transgenic (7-1B-3-




These results suggest that EST 13803210 is not a key player in bradyzoite formation.  It 
could be involved but is not sufficient to induce bradyzoite differentiation.  
3.2.6 Cosmid complementation in mutant B7 restores the mutant phenotype to 
wild type-like levels. 
 Mutant B7 was complemented using the 40kb cosmid, PSBLS72 (generous gift 
from M. Gubbels).  This cosmid contained six genes including B41 (Figure 25). 
 
Figure 25. A schematic of the cosmid used to complement the mutant B7 phenotype 
and the genes that are located on this cosmid. 
 
Mutant parasites were transfected with the cosmid and stable lines were selected with the 
drug, phleomycin.  Transgenic parasites were then subjected to bradyzoite induction 
conditions for 72h and expression of bradyzoite-specific surface antigen (4F8) was 
measured as the number of positive vacuoles per 100 vacuoles counted.  The 
complemented parasite line (B7 complement) was compared to wild type (parental 7-1) 
and mutant B7 (Figure 26). 
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 Figure 26. Immunofluorescence assay of the expression of a bradyzoite surface 
antigen in wild type, mutant B7 and B7 complement shows increased expression in 
the B7 complement compared to mutant B7. 
 
Replication rate was also measured in the B7 complemented strain and compared to wild 
type and mutant B7 (Figure 27). 
 
Figure 27. Replication rate assay shows that B7 complement has reduced replication 





After 3 days of bradyzoite induction the average number of parasites per vacuole were 
counted in the B7 complement and compared to wild type and mutant B7.  Interestingly, 
the complemented strain shows reduced replication rate but not reduced to the level of 
wild type.   
 In conclusion, cosmid complementation restored the mutant phenotype to wild 
type-like levels.  It is important to note that B41 is the only gene on cosmid PSBLS72 
that has its expression affected in the mutant and this result adds to the evidence 
supporting our hypothesis that B41 is responsible for the mutant phenotype.  
Interestingly, the 40kb cosmid was sufficient for complementation mutant B7 but the 
plasmid containing only the B41 gene was not able to complement the mutant.  The 
original plasmid used for complementing mutant B7 contained the entire B41 gene 
(2.2kb) plus 1000bp upstream from this gene in order to capture the endogenous 
promoter of B41.  The cosmid contains the entire B41 gene including ~7500bp of 
genomic sequence down stream from the 3’end of the B41 gene and ~31,000bp upstream 
from the transcription start site of B41.  Our results suggest that there are functionally 
important sequences within the cosmid that were not included in the orginal plasmid that 
allowed for complementation of mutant B7. 
3.3 Methods 
Parasite growth and differentiation. 
 The parental line, RH ΔHXGPRT ΔUPRT (deleted at both HXGPRT and UPRT 
loci; Bohne and Roos, 1997), and mutant B7 tachyzoites were maintained by serial 
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passage in primary cultures of human foreskin fibroblast (HFF) cells, as described 
previously (Roos et al., 1994). ΔUPRT tachyzoite parasites can be induced to form 
bradyzoites in vitro when subjected to low CO2 conditions (0.03%) resulting in 
pyrimidine starvation (Roos et al., 1994; Boothroyd et al., 1995).  Bradyzoite induction 
was accomplished by inoculating tachyzoites into an HFF host cell monolayer in minimal 
essential media without NaHCO3 that contains Earles salts 25mM HEPES (Gibco).   The 
cultures were then equilibrated at pH7 and incubated at 37°C.  All measurements were 
taken on extracellular tachzoites or 72h post induction bradyzoites. 
RNA Isolation. 
Total RNA was extracted from freshly egressed, extracellular, tachyzoites or 72h post 
induction bradyzoites.  Infected monolayers were scraped, dounce homogenized and 
filtered through a 3micron filter (Millipore).  Parasites were centrifuged and washed 2 
times with 1X phosphate buffered saline (PBS) in DEPC water.  Pellets were resuspened 
in lysis buffer RLT (Qiagen) and passed through a 26G needle.  Finally, samples were 
processed through the RNA mini kit (Qiagen) and DNase treated on the column.  (Elution 
with 50°C RNase-free water increased our yield).  RNA concentrations were measured 
on the NanoDrop ND 1000 UV Vis spectrophometer.   
Luciferase Assays 
Wild type parasites were transiently transfected with pLUC, EST-LUC or B41-EST-
LUC.  Primers used to generate the LUC constructs are as follows: 969-ApaI: 5’ 
ATCGTCGGGCCCAGGCGTCTGCGTCGATGG 3’, 3775-ApaI: 5’ 
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ATCGTCGGGCCCACTGGGGGAGGAAGCTCCTAC 3’, 4640-BglII: 5’ 
GTTGGAAGATCTTGTGATGAGAGACGTTTTCTCG 3’. pLUC was digested with 
ApaI/BglII and ligated with EST promoter (PCR product 3775-ApaI/4640-BglII) or B41-
EST promoter (969-ApaI/4640-BglII).  Parasites were tranfected with the constructs and 
selected with chloramphenicol to select for stable transgenic lines.  Bradyzoite induction 
conditions used in this experiment were CO2 starvation conditions.  Luciferin subtrate 
was reconstituted with buffer, media was apirated from cells/parasites, washed with 1X 
PBS, 900ul 1X CCLR  was added to cover cells, cells were scraped and added to a tube 
on ice and luciferase activity was measured on a luminometer. 
Immunofluorescence Assays 
HFF cells were grown on coverslips within a 6-well plate and inoculated with 
extracellular tachyzoites.  Parasites were grown under tachyzoite or bradyzoite conditions 
for 72 hours.  In brief, the cells were washed with 1X PBS and fixed in methanol.  Next 
cells were washed in 1X PBS and then blocked in 1X PBS + 1% BSA for 30 minutes at 
room temperature.  Each sample was subjected to the primary antibody, 4F8 (1:500 
dilution in 1X PBS + 1% BSA), for 1 hour at room temperature.  After 3 washes with 1X 
PBS, samples were incubated with the secondary antibody, 488 anti-mouse (1:1000 in 1X 
PBS + 1% BSA), and Dolichos lectin (1:100 in 1X PBS + 1% BSA) for 1 hour at room 
temperature.  Finally, samples were washed with 1X PBS, rinsed in distilled water and 
mounted on a coverslip with Fluoromount-G. 
Quantitative RT-PCR. 
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qRT-PCR, TaqMan, was performed according to the manufacturer (Qiagen).  The 
following primers and probes were used: B41-forward: 5’ 
TGCACACTAAGGCGTACATCAAT 3’, B41-reverse: 5’ 
TGACAGGAGGCGCACAGTT 3’, B41-probe: 5’ 
[DFAM]CAGCTGAGTCGCCGTCGAAACG[DBH1] 3’. 
Overexpression of EST 13803210 
The following primers were used to contruct the alpha-tubulin promoter-EST plasmid: 
BamHI-forward: 5’ ATTCGCGGATCCAAAATGCCTGCGGTCTATTGCC 3’, AvrII-
reverse: 5’ CTCTTACCTAGGAGCGGGGGTGAAGAGGGAAG 3’, NotI-reverse: 5’ 
TTTTCCTTTTGCGGCCGCCTTCAGTCCAGACTTTAGGC 3’.  The template used 
was cDNA EST13803210 (~1.0kb) and genomic DNA EST13803210 (~2.2kb).  Parasites 
were transfected, subjected to bradyzoite induction conditions and immunofluorescence 
assay of bradyzoite-markers were performed. 
RACE 
The following primers were used for 5’ and 3’ RACE: B41-GSP2: 5’ 
CCGGGTGTCTTCATCTGTTCGTACTTTG 3’, B41-GSP1: 5’ 
GACGGCACTGTAATGTATTTGGGTCCAC 3’, B41-NGSP2: 5’ 
CGATCTGTGTCACTTTGTAGACGCCAAG 3’, B41-NGSP1: 5’ 
CTGAAATGGCCCACGGCATTTGAAC 3’, B41-GSP3: 5’ 
TATCAGAAACTGCTCGAGGATCG 3’(to move further towards the 5’ end of gene), 
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B41-GSP4: 5’ ATCGATCGATCCAGACGTTC 3’(to get additional sequence at 3’ end 
of shorter transcript), B41-GSP5: 5’ ATGTCTCCTGGGGACTGCGTTCTCG 3’(to get 
additional sequence at 3’ end of larger transcript). 
Cosmid complementation. 
Each transfection was performed with 40μg of DNA and stable transgenic lines were 
selected with phleomycin (D. Sibley protocol) 
3.4 Discussion 
 Bradyzoite differentiation mutant B7 has been disrupted in a putative ncRNA, 
B41.  B41 is a large, alternatively polyadenylated, ncRNA that is developmentally 
regulated.   Overexpression of EST 13803210 does not cause the mutant phenotype 
therefore, this EST is not a key player in bradyzoite formation.  Unfortunately we were 
unable to elucidate the function of B41 since luciferase reporter assays used to test if B41 
regulated the EST 13803210 proved to be negative and other attempts towards 
elucidation have been technically difficult (data not shown, P. Lescault).  However, 
several lines of evidence point to B41 as being the gene responsible for the mutant 
phenotype; B41 is physically disrupted by the insertion, B41 is the only gene within 
100kb of the insertion that has its expression affected in the mutant, and a cosmid 
containing B41 complemented mutant B7.
 CHAPTER 4: EPILOGUE 
 
4.2 The new experimental design 
 Our current data, along with the Roos laboratory’s time course, suggests that wild 
type parasites grown under bradyzoite induction conditions (low CO2) for 24h are ‘true’ 
intracellular tachyzoites, ie., show the same expression profile as wild type parasites 
grown under tachyzoite growth conditions (high CO2) (Figure 28).   
 
 
Figure 28. Clustering of early genes show how our 24h time point (intracellular low 
CO2 parasites) express the same as the Roos lab time 0h (intracellular parasites 24h 
post invasion). 
 
The first aim of the new experimental design is to validate this result by performing 
microarray analysis on wild type parasites grown under high and low CO2 conditions for 
24h and then to compare the data for similarities/differences.  Our current data also 
suggests that 5/7 mutant parasite lines (B7 family), harvested in the extracellular state 
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under high (‘freshly’ egressed “t = 0h”) and low (72h post induction) CO2, show similar 
expression profiles to wild type intracellular tachyzoites, while 2/7 extracellular mutant 
parasite lines (13P family) only show this similarity under low CO2 (72h post induction) 
and behave like wild type under high CO2 (‘freshly’ egressed “t = 0h”).  Given that the 
harvest time point of ‘freshly’ egressed (under high CO2) could have taken place over a 
range of time (anywhere up to ~10h), unlike a specific time point such as 72h post 
induction, we will perform microarray analysis on a time course of egress under high 
CO2.  This latter aim serves to rule out that our observation (extracellular mutants behave 
like intracellular wild type) is not just due to variable time in harvest at t = 0h.  Perhaps, 
mutant parasites were harvested at a time when they were visibly extracellular but had 
not had enough time to ‘recognize’ that they were outside of the host and, thus, still 
expressed a similar profile to intracellular parasites.  Whereas, wild type extracellular 
parasites had been egressed at such a time during egress where they do recognize that 
they are outside of the host and, thus, do express the profile of an extracellular parasite. 
 The new experimental design required to validate the inferences made in our 
current microarray analysis study, will consist of the following parameters: 
 
Number of microarray chips: 8 
Parasite lines: (3); wild type-parental RH 7-1, Mutant B7 (to represent the ‘B7 family’; 
B7, 11K, 11P, 7K and P11), and Mutant 13P (to represent the ‘13P family’; 13P and 
12K) 
 73
Harvest timepoints:  
·         Wild type: 
o High CO2- 24h- intracellular 
o Low CO2- 24h intracellular 
o High CO2- 0h- ‘freshly’ egressed 
o High CO2- 0+8h- ‘completely’ egressed 
·         Mutant B7: 
o   High CO2- 0h- 'freshly' egressed. 
o   High CO2- 0+8h- 'completely egressed. 
·         Mutant 13P: 
o   High CO2- 0h- 'freshly' egressed. 
o   High CO2- 0+8h- 'completely' egressed. 
4.2.1 Confirmation that intracellular parasites grown under low CO2 for 24h 
represent ‘true’ intracellular tachyzoites (grown under high CO2 for 24h) 
 We will perform microarray analysis on the following samples; High CO2- 24h- 
intracellular and Low CO2- 24h- intracellular.   We hypothesize that these two samples 
are similar and if we obtain this result then we can extrapolate the following; 
ET.High/LowCO2(B7) = IT.HighCO2(WT) and ET.LowCO2(13P) = IT.HighCO2(WT).  
However, if we observe that wild type intracellular parasites grown under high CO2 (24h) 
are different from wild type parasites grown under low CO2 (24h) then we will simply 
state that ET.High/LowCO2(B7) = IT.LowCO2(WT) and ET.LowCO2(13P) = 
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IT.LowCO2(WT).  It is not immediately clear to me how this alternative result could be 
biologically relevant but nonetheless, it is a clear observation. 
4.2.2 Confirmation that extracellular mutants behave like wild type intracellular 
tachyzoites 
(1) Confirmation of results for the mutant B7 family.  
 We hypothesize that our observation that ET.HighCO2(B7) ≠ ET.HighCO2(WT) 
is independent of time after egress (within the doubling time of a parasite).  In order to 
confirm our hypothesis about the mutant B7 family, we will perform microarray analysis 
on the following samples: 
(WT)High CO2- 0h- 'freshly' egressed(A) 
(WT)High CO2- 0+8h- 'completely' egressed(B) 
(B7)High CO2- 0h- 'freshly' egressed(C) 
(B7)High CO2- 0+8h- 'completely' egressed(D) 
Our hypothesis states that the comparison of these four samples will yield the following: 
o   A ≠ C 
o   A ≠ D 
o   B ≠ C 
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o   B ≠ D 
It is completely irrelevant if A = or ≠ B and if C = or ≠D. 
 However, if we observe the following result, A = C and/or D or B = C and/or D, 
then our alternative hypothesis would be that under high CO2 mutant B7 behaves like WT 
in a time-after-egress dependent manner.  If this is the case then we have now shown that 
our previous result  (extracellular B7 and WT are different under HighCO2) was an 
'artifact' due to inadequate control of the 'egressed' timepoint.  
(2) Confirmation of results for the mutant 13P family. 
 The 13P family of mutant behave like extracellular wild type parasites under high 
CO2 but look like intracellular tachyzoites under low CO2 (72h post induction).  In this 
set of experiments, we want to show how the mutant 13P family are distinct from the 
mutant B7 family with respect to our previous results (5/7 mutants (B7 family) behave 
like this: ET.High/LowCO2(MUT) ≠ ET.HighCO2(WT); 2/7 mutants (13P family) look 
like this: ET.HighCO2(MUT) = ET.HighCO2(WT), but ET.LowCO2(MUT) ≠ 
ET.HighCO2(WT)).  In order to confirm this results we will perform microarray analysis 
on the following samples: 
(WT)High CO2- 0h- 'freshly' egressed(A) 
(WT)High CO2- 0+8h- 'completely' egressed(B) 
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(13P)High CO2- 0h- 'freshly' egressed(E) 
(13P)High CO2- 0+8h- 'completely' egressed(F)  
We hypothesize that the comparison of these four samples will yield the following: 
A = E and/or F 
B = E and/or F 
Again, it is completely irrelevant if A = or ≠ B and if E = or ≠F.  
4.3 Specification Reports for interesting genes and gene sets. 
 During our microarray analysis, we spent a good amount of time thinking about 
what types of analyses would best describe the attributes of a given gene or set of genes 
of interest.  The idea was that we wanted to create the ultimate ‘standardized’ report that 
would be informative and clear to the researcher and then we could systematically 
reproduce this report for any given gene in an efficient manner.  One such report that we 
came up with consisted of 4 main analyses; DE plots, Box and Whisker plots, Principle 
Components Analysis and an Expression Values/Annotation Table.  Each of these 
analyses has its own set of parameters that must be defined and once the program is 
written it can be used over and over again to produce a standardized report for any given 
gene or set of genes.  The beauty of producing these reports in this manner is that the 
only unique input needed for each report consists of the gene or genes of interest for that 
given report and then all of the analysis is automatic.  With this reporting mechanism we 
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can produce a spec report for any given gene or gene set in a matter of minutes allowing 
for a more efficient way to analyze and interpret the microarray data, which is needed 
when you are trying to trudge your way through an enormous amount of information. 
 DE plots are useful for illuminating the overall ‘big picture’ features for all genes 
between two samples and seem to be what most people are well acquainted with.  The 
reason why a DE plot would contribute to the report is because we can highlight the gene 
or set of genes of interest on the plot so that it stands out among all other genes and the 
researcher will be able to interpret how their favorite gene or set of genes compares to the 
rest of the genes for any two samples.  The comparison of samples may include any 
combination of the following; wild type vs. mutant, mutant-1 vs. mutant-2, wild type vs. 
all mutants, replicate-1 vs. replicate-2 and so on.  Box and Whisker plots are useful for 
detecting patterns of gene expression across samples.  In this analysis it may be 
informative to know where your favorite gene lies along the box and whisker of a given 
sample or set of samples.  It may also be useful to look at the pattern(s) of expression for 
a given set of genes and see how the pattern changes/remains the same across samples.  
Principle Components Analyisis (PCA) is a statistical method that finds patterns among 
samples given data of high dimension.  For example, in our current microarray analysis, 
we had 55 samples (including replicates) and ~8000 gene expression values for each 
sample; data of high dimension.  For this example, PCA will take into account the level 
of variation in expression across all samples (55 components) and then plot the samples 
using the top two components that consist of the most variation.  In short, the PCA plot is 
useful for visualizing which samples behave most like each other (in close proximity to 
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each other on the plot) and most different from each other (further away from each other 
on the plot).  Additionally, PCA can illuminate a trend or pathway of gene expression 
from one to sample to the next as in a time course.  Finally, the usefulness of the 
Expression Value/Annotation Table is to be able to connect how your favorite gene is 
behaving in the context of biology (the annotation consisting of gene name, gene 
ontology terms, etc.).  In conclusion, I think that the design and implementation of the 
specification report is an extremely useful tool for expediting analysis and interpretation 
and I am grateful that I had the opportunity to work through the thought process involved 
in creating such an ‘ultimate’ standardized reporting mechanism. 
4.4 Addressing the human RNA contamination concern 
 Since Toxoplasma gondii are obligate intracellular parasites we will undoubtedly 
have human (host cell) RNA contamination in our RNA preparations.  There are two 
reasons why we can rule out that human contamination affected our data: (1) 
bioinformatics were used to access every human probe considered to be put on the 
Toxochip before it was put onto the microarray chip to make sure that there would be no 
cross hybridization and (2) we ran microarray analysis on two biological replicates of 
wild type bradyzoite samples that had 50% human contamination (according to the RNA 
Chip assessment comparing human and Toxoplasma ribosomal RNAs) and the probe set 
intensities for these chips were comparable to the intensities of chips that had very little 
(<5%) human contamination. 
4.5 The B41 gene sequence and open reading frame predictions are similar 
between Type I, Type II, and Type III strains of Toxoplasma gondii. 
 We hypothesize that B41 is a noncoding RNA because it has no substantial open 
reading frame (ORF) but is transcribed.  It is nonetheless possible that B41 encodes for a 
small protein.  B41 has several small ORFs (~3amino acids (aa) - 85aa) that are defined 
by a nucleotide sequence in any of the six reading frames that has a 5’ end ATG 
nucleotide triplet and a 3’ end stop codon (Figure 29).   
 
Figure 29. The small open reading frames predicted for the six reading frames of 
the B41 gene. 
 
Computational analysis might allow us to quantitatively support or reject our hypothesis 
that B41 is a noncoding RNA, but the amount of information available is likely 
inadequate for a definitive conclusion.  This type of analysis would involve the prior 
probability that an expressed gene is protein coding as well as the conditional 
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probabilities of having a maximum ORF length of 85aa in each of the protein coding and 
non-protein coding genes.  This would allow us to quantify, for example, the extent to 
which a maximum ORF of length 85aa provides evidence against a protein product, but 
would likely not rule out a small protein product.  The computational analysis would also 
include analysis of the B41 sequence variation among the three strains.  For example, if 
the ORF was expressed as a protein then we would expect to observe more selection 
against non-synonymous changes than synonymous changes, which should have 
relatively less effect on protein function. 
 We analyzed the primary DNA sequence of the B41 gene across the three major 
strains (Figure 30) and found that type II and type III are identical.   
 
Figure 30. Comparison of nucleotide sequence reveals that types II and III are 
identical to each other and slightly different from type I. 
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However, there are 24 single nucleotide changes within the B41 gene for type I compared 
to types II /III and these changes account for a 1% identity difference.  Interestingly, the 
single nucleotide changes do not fall within the longest  (85aa) ORF and so would not 
affect that ORF if it were real.  We can calculate the probability for the 24 nucleotide 
changes to occur outside of the 85aa ORF under the null hypothesis; 
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p = (1 - ((85)(3)base pairs/2600base pairs))24 = 0.08, which is >0.05. 
This result means that we cannot reject the possibility that chance accounts for the 
observation that none of the 24 nucleotide changes occurred in the 85aa ORF. 
 In conclusion, we expect that computational analysis would not be sufficient to 
quantitatively support or reject our hypothesis that B41 is a non-protein coding gene and 
feel that laboratory experiments (such as mass spectroscopy) would have to be performed 
in order to determine whether small proteins are expressed from the B41 gene. 
4.6 Future Directions for studying the bradyzoite differentiation mutants 
4.6.1  Promoter motif search: looking for common motifs in functionally similar co-
expressed gene sets. 
 Microarray analysis of wild type parasites reveals distinct subsets of genes that 
are co-expressed at different time points during the tachyzoite to bradyzoite transition.  I 
would like to examine the promoter regions of the co-expressed genes to see if I could 
identify similar motifs that may contribute to the mechanism by which they are co-
expressed.  It is interesting to me that the Toxoplasma gondii genome does not contain 
traditional transcription factors or their corresponding motifs.  For example, the 
Toxoplasma gondii genome does contain a gene that has strong homology to the TATA-
binding protein, yet there are no obvious TATA box motifs.  It would be of great interest 
to figure out what types of mechanisms Toxoplasma gondii uses to control its gene 
expression.  Given that we now have 3 distinct subsets of genes that are co-expressed, we 
should be able to break up each subset into groups with common function and then to 
align the promoters (2000bp upstream of the translation start site in attempts to capture 
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the entire promoter) and look for consensus sequences that have significant similarity.  I 
would venture to guess that the consensus sequence(s) that we find with one subset of co-
expressed genes would be different from the consensus sequence(s) we find in the other 
subset of co-expressed genes and that those differences may account for the difference in 
timing and/or extent of expression during the tachyzoite to bradyzoite transition.  One 
other way to show that the similarities in sequences within one subset of co-expressed 
genes is quite different compared to the similarities in sequences seen in another subset of 
co-regulated genes would be to make a phylogenetic tree of the promoters from both 
families (two distinct subsets of co-expressed genes) and look for the segregation of 
promoters based on common features. 
4.6.2 Taking a closer look at the expression pattern across entire chromosomes. 
  
 Preliminary analysis of the expression profiles of wild type compared to mutant 
B7 across entire chromosomes revealed something quite interesting.  There are several 
chromosomes that show a distinct pattern of expression across the entire chromosome.  
An example of this pattern is shown in Figure 31 (below). 
 Figure 31. Example of what seems to be an unusally non-random pattern of 
expression across an entire chromosome. 
 
This non-random pattern of expression across the entire chromosome could have 
important implications for how Toxoplasma gondii regulates it gene expression during 
the bradyzoite differentiation process. 
4.4.3 Analysis of genes with a high R score. 
  
 Our microarray analysis of the seven bradyzoite differentiation mutants compared 
to wild type allowed us to identify genes that showed the highest variation in expression 
levels among all samples.  It would be interesting to follow up on these genes and to 
figure out how they might be involved in the differentiation process.  For example, one 
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gene that has the highest R score is a hypothetical gene (551.m00236) and is exclusively 
overexpressed in mutant 7K compared to all other mutants.  One experiment that may 
give us more insight into whether or not this gene is a key player in bradyzoite formation 
would be to overexpress this hypothetical gene in wild type parasites and then induce the 
transgenic line to form bradyzoites.  It would be interesting if overexpression of this gene 
caused the mutant phenotype.  It may also be useful to search through the top ~100 genes 
that have the highest R scores and look to see if there is a subset of genes that are highly 
expressed in mutant 7K (or your favorite mutant) compared to all samples and take a 
closer look into those genes.  I think the R Score analysis is going to prove to be a very 
useful tool for further study of our bradyzoite differentiation mutants that we have at 
hand (12K, 13P, B7, 11K, 11P, 7K and P11). 
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